Polysaccharide-Targeting Lipid Nanoparticles to Kill Gram-Negative Bacteria

Area of Science:

• Microbiology
• Nanotechnology
• Infectious Diseases

Background:

• Rising antimicrobial resistance in Gram-negative bacteria poses a significant global health threat.
• Bacterial polysaccharides hinder antimicrobial penetration and immune system evasion, contributing to pathogenicity.
• Current antibiotics lack mechanisms to target these crucial polysaccharide structures.

Purpose of the Study:

• To develop and evaluate novel lipid nanoparticles targeting bacterial polysaccharides.
• To assess the efficacy of monolaurin-based niosomes in combination with polymyxin B against Klebsiella pneumoniae.
• To elucidate the multimodal mechanism of action of this novel antimicrobial system.

Main Methods:

• Development of monolaurin-based niosomes as lipid nanoparticles.
• In vitro cytotoxicity assays and in vivo infection models using Klebsiella pneumoniae.
• Mechanistic studies to understand the disruption of bacterial polysaccharides and membranes.

Main Results:

• Monolaurin-based niosomes effectively eliminated bacterial polysaccharides from hypervirulent Klebsiella pneumoniae.
• The combination of niosomes and polymyxin B demonstrated high efficacy in vivo with no observed cytotoxicity.
• A synergistic multimodal mechanism involving polysaccharide disruption and membrane destabilization was identified.

Conclusions:

• Monolaurin-based niosomes represent the first lipid nanoparticles capable of eliminating bacterial polysaccharides.
• This novel system shows significant promise as a potent antimicrobial treatment for multidrug-resistant Gram-negative pathogens.
• The synergistic approach offers a new avenue for combating challenging bacterial infections.